Bio-Works Technologies AB (publ)

NGM:BIOWKS Stock Report

Market Cap: SEK 64.7m

Bio-Works Technologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lone Carlbom

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure4.6yrs

Recent management updates

Recent updates

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Dec 25
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Aug 30
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Feb 21
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Oct 25
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

May 10
We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Sep 27
Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

May 11
Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

Mar 20
Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

Dec 05
How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

CEO

Lone Carlbom

less than a year

Tenure

Ms. Lone Carlbom is Chief Executive Officer of Bio-Works Technologies AB (publ) from May 17, 2024. Ms. Carlbom has broad experience in leadership roles within the Life Sciences and Biotech industries, with...


Leadership Team

NamePositionTenureCompensationOwnership
Lone Carlbom
Chief Executive Officerless than a yearno datano data
Jan Berglöf
Co-Founder & Senior Advisor4.1yrsno datano data
Arne Hauge
CFO & Head of Support Functions1.3yrsno datano data
Karsten Fjärstedt
Chief Operating Officerless than a yearno datano data
Helena Pahlm
Senior Director of Global Qualityno datano datano data
Silvia Hellstrom
Head of Quality Assuranceno datano datano data
Maria Åberg
Head of Productionno datano datano data
Anne Dyrdal
Chief Commercial Officerless than a yearno datano data

0.9yrs

Average Tenure

Experienced Management: BIOWKS's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter von Ehrenheim
Independent Chairman of the Board5.3yrsSEK 237.00k1.53%
SEK 988.9k
Thomas Gür
Directorless than a yearno datano data
Peter Nahlstedt
Independent Board Director4.6yrsSEK 118.00kno data
Kirsti Gjellan
Independent Board Director6.6yrsSEK 118.00kno data
Jurgen Hubbuch
Member of Scientific Advisory Boardno datano datano data
Jean Bender
Member of Scientific Advisory Boardno datano datano data
Eun Lee
Member of Scientific Advisory Boardno datano datano data
Per Möller
Member of Scientific Advisory Boardno datano datano data
Jorg Thommes
Member of Scientific Advisory Boardno datano datano data
Jonas Ahlen
Directorless than a yearno datano data

4.6yrs

Average Tenure

63yo

Average Age

Experienced Board: BIOWKS's board of directors are considered experienced (4.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 06:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bio-Works Technologies AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Klas PalinPenser Access